Today (2017 C.E. - 2025 C.E.)

This archive spans one of the most eventful periods in recent history, from 2017 through 2025. Browse more than 4,100 articles documenting scientific breakthroughs, policy wins, social progress, and human ingenuity from the present era. Each story highlights what people and communities around the world are building, solving, and achieving right now.

A medical professional reviewing cancer treatment data for an article about cervical cancer survival

U.K. scientists cut cervical cancer death risk by 35% in major trial

Cervical cancer survival rates could improve dramatically after a major clinical trial found that adding a short course of chemotherapy before standard treatment reduces the risk of death or recurrence by 35%. Led by University College London researchers and funded by Cancer Research U.K., the trial showed 80% of women using the new approach were alive at five years, compared to 72% receiving standard treatment alone. The finding is considered the biggest advance in cervical cancer outcomes in over 20 years. Crucially, the drugs involved are already approved, widely available, and inexpensive, meaning the protocol could be adopted globally without new approvals or manufacturing delays.